Navigation Links
Sleeping Pills Linked to Raised Risk of Death, Cancer: Study
Date:2/28/2012

By Denise Mann
HealthDay Reporter

MONDAY, Feb. 27 (HealthDay News) -- Prescription sleeping pills may help you get some much needed rest at night, but using them routinely might also make it more likely that you will die or develop certain types of cancer, research suggests.

A new study suggests that those who take these medications are four times more likely to die than people who don't take them. What's more, the research shows that sleeping pill use is also associated with a raised risk for certain cancers. The findings appear online Feb. 27 in the journal BMJ Open.

Sleeping pills linked to these risks included benzodiazepines such as temazepam; non-benzodiazepines such as Ambien (zolpidem), Lunesta (eszopiclone) and Sonata (zaleplon); barbiturates; and sedative antihistamines.

The new study only shows an association between the sleeping aids and death risk, not cause-and-effect, and many experts are urging caution in jumping to any conclusions from the findings.

The study author, however, was less reticent.

"Popular sleeping pills are associated with a shocking excess of deaths and a horrible increase in new cancers," said Dr. Daniel Kripke, of the Scripps Clinic Viterbi Family Sleep Center, in La Jolla, Calif.

Many Americans use sleeping pills. During 2010, between one in 20 and one in 10 adults took a sleeping pill in the United States.

In the new study, Kripke's team tracked more than 10,500 people averaging 54 years of age. These patients had a range of underlying health conditions and were prescribed sleeping pills for an average of about 2.5 years between 2002 and 2007. The researchers compared these patients' risks for death and cancer against those of people who did not take sleeping pills.

Those who were prescribed up to 18 doses a year were 3.6 times more likely to die than their counterparts who were prescribed none, while those prescribed between 18 and 132
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Sleeping sickness drug may provide long-term protection against skin cancer
2. Sometimes Sleeping on the Job May Be a Good Thing
3. Cautionary tale for people with diabetes: Dog consumed part of a sleeping patients toe
4. Could Sleeping on Left Side Help Prevent Stillbirth?
5. Sleeping through danger: the dormouse approach to survival
6. Scientists seek urgent treatment for fatal sleeping sickness
7. Most Babies Start Sleeping Through Night at 2 to 4 Months
8. Our children arent sleeping and were medicating them
9. Sleeping well at 100 years of age: Study searches for the secrets to healthy longevity
10. National Sleep Awareness Week(R) (March 7-13): How Are You Sleeping?
11. Many Vegetarians Unaware of Animal-Derived Gels in Pills
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sleeping Pills Linked to Raised Risk of Death, Cancer: Study
(Date:7/31/2015)... York, New York (PRWEB) , ... July 31, 2015 , ... ... to strut their stuff, Super-Sod debuted their new type of sod called Leisure ... registered trademark application in process. , To commemorate introduction of this new type of ...
(Date:7/31/2015)... ... ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, CA on ... Super Bowl. In the two weeks that separate the conference championships and the Super Bowl, ... Bowl game will mark the 50th time it has been held and the festivities will ...
(Date:7/31/2015)... ... July 31, 2015 , ... Precision Aesthetics is New York’s only ... was also the first provider of Exilis non-surgical fat reduction in New York. ... has attracted a large International clientele. Many patients travel to New York to ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... new store run by GoodThreads. The store can be accessed by visiting ... many of which are customizable. The best part: whenever a product is purchased, ...
(Date:7/31/2015)... ... July 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics announces the ... Zeltiq Aesthetics released this new applicator in the United States as an upgrade ... outer thighs. The original applicator required a 2 hour treatment time. The ...
Breaking Medicine News(10 mins):Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3
... Philadelphia, PA Louis J. Soslowsky, Ph.D. Fairhill ... director of the McKay Orthopaedic Research Laboratory and ... of Pennsylvania School of Medicine, was named the ... Delta Award by the American Academy of Orthopaedic ...
... ... at Johns Hopkins Medical Institutions, the Karolinska University Hospital and Institute, and The Feinstein ... , ... (Vocus) March 10, 2010 -- An experimental thyroid drug reduces cholesterol without the troublesome ...
... ... Improves Team Collaboration and Efficiency , ... San Francisco, CA (PRWEB) March 10, 2010 -- Manymoon announced today ... in the Google Apps Marketplace™, Google,s recently launched online storefront for Google Apps™ products ...
... , ... , ... ... ANN ARBOR, Mich. , March 10 Many Americans will lose an hour of sleep on March 14 ...
... Discovery in mouse study may someday extend men,s lives, ... therapy has proven useful in treating late-stage prostate cancer, ... tumors that are resistant to such therapy. , Now, ... a mechanism by which the secondary tumors gain their ...
... ... Recognized for PrescriptionDrugs.com Business Plan , ... Boston, MA (PRWEB) March 11, 2010 -- A week from today, ... ever HBS Alumni New Venture Contest . PrescriptionDrugs.com co-founder Mike “Zappy” Zapolin will ...
Cached Medicine News:Health News:Penn researcher, Louis J. Soslowsky, PhD, winner of the AAOS Kappa Delta Ann Doner Vaughan Award 2Health News:Penn researcher, Louis J. Soslowsky, PhD, winner of the AAOS Kappa Delta Ann Doner Vaughan Award 3Health News:Thyroid Hormone Analogue for Treating High Cholesterol 2Health News:Thyroid Hormone Analogue for Treating High Cholesterol 3Health News:Manymoon Now Available Through the Google Apps Marketplace 2Health News:Manymoon Now Available Through the Google Apps Marketplace 3Health News:Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says 2Health News:Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says 3Health News:Daylight-Saving Time Switch May Leave You Sleepy, U-M Physician Says 4Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 2Health News:Scientists Find Key to Hormone-Resistant Prostate Tumors 3Health News:PrescriptionDrugs.com and Mike “Zappy” Zapolin Have Been Selected to Compete in Harvard Business School New Venture Contest 2Health News:PrescriptionDrugs.com and Mike “Zappy” Zapolin Have Been Selected to Compete in Harvard Business School New Venture Contest 3
(Date:7/30/2015)... SAN DIEGO, July 30, 2015  ResMed Inc. (NYSE: ... ended June 30, 2015.  Revenue for the quarter was ... quarter ended June 30, 2014 (a 17 percent increase ... million, consistent with the quarter ended June 30, 2014. ... consistent with the quarter ended June 30, 2014.  ...
(Date:7/30/2015)... VANCOUVER , July 30, 2015  OncoGenex Pharmaceuticals, ... will report its second quarter 2015 financial results on ... conference call and live webcast at 4:30 p.m. Eastern ... development programs and a general corporate update. ... Investor Relations page of the OncoGenex website at ...
(Date:7/30/2015)... July 30, 2015  Cleveland Clinic President Wael ... address last month that industry is compelled to adopt ... gain the efficiencies—and develop the transformational innovations -- required ... comments were preceded by Doug Kohrs , past ... moderator, who stressed that industry must add "episode of ...
Breaking Medicine Technology:ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... YORK, July 19, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0574348/European-Medical-Displays-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging This research ... market in terms of the challenges faced ...
... drug companies face a number of obstacles to commercialize ... (FDA) and GMP compliance, to distribution agreements and the ... must be coordinated.  Those issues have just become easier ... VPCI have entered into a joint association.  The collaboration ...
Cached Medicine Technology:European Medical Displays Markets 2European Medical Displays Markets 3European Medical Displays Markets 4Spanish Drug Companies Have New Support Option for the U.S. Market 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: